Linc00673-V3 positively regulates autophagy by promoting Smad3-mediatedLC3Btranscription in NSCLC

Author:

Ni Heng12,Tang Song1,Lu Guang3ORCID,Niu Yuequn12,Xu Jinming2,Zhang Honghe4,Hu Jian2,Shen Han-Ming56,Wu Yihua1ORCID,Xia Dajing1ORCID

Affiliation:

1. Department of Toxicology of School of Public Health and Department of Gynecologic Oncology of Women’s Hospital, Zhejiang University

2. Department of Thoracic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University

3. Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China

4. Department of Pathology and Women’s Hospital, Zhejiang University

5. Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

6. Faculty of Health Sciences, Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, Macau, China

Abstract

Since its first discovery, long noncoding RNA Linc00673 has been linked to carcinogenesis and metastasis of various human cancers. Linc00673 had five transcriptional isoforms and their biological functions remained to be explored. Here we have reported that Linc00673-V3, one of the isoforms of Linc00673, promoted non–small cell lung cancer chemoresistance, and increased Linc00673-V3 expression level was associated with enhanced autophagy. Mechanistically, we discerned the existence of a stem-loop configuration engendered by the 1–100-nt and 2200–2275-nt fragments within Linc00673-V3. This structure inherently interacted with Smad3, thereby impeding its ubiquitination and subsequent degradation orchestrated by E3 ligase STUB1. The accumulation of Smad3 contributed to autophagy via up-regulation ofLC3Btranscription and ultimately conferred chemoresistance in NSCLC. Our results revealed a novel transcriptional regulation network between Linc00673-V3, Smad3, andLC3B, which provided an important insight into the interplay between autophagy regulation and non-canonical function of Smad3. Furthermore, the results from in vivo experiments suggested Linc00673-V3 targeted antisense oligonucleotide as a promising therapeutic strategy to overcome chemotherapy resistance in NSCLC.

Funder

MOST | National Natural Science Foundation of China

MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province

Key Research and Development Program of Zhejiang Province

CAMS Innovation Fund for Medical Sciences

Fundamental Research Funds for the Central Universities

Key R&D Program of Zhejiang

Publisher

Life Science Alliance, LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3